Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 4, 2020
Determining generalizability of the Canadian Kidney Cancer information system (CKCis) to the entire Canadian kidney cancer population
Camilla Tajzler, Simon Tanguay, Ranjeeta Mallick, et al.
Clinical Genitourinary Cancer
|
May 7, 2019
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205
Sebastien J Hotte, Kim N Chi, Anthony M Joshua, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 8, 2018
Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials
Pierre I Karakiewicz, Emanuele Zaffuto, Anil Kapoor, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 15, 2023
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement
Aly-Khan A Lalani, Anil Kapoor, Naveen S Basappa, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
February 21, 2024
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum
Fred Saad, Sebastien J Hotte, Krista Noonan, et al.
JAMA Network Open
|
April 15, 2026
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
Martin Zarba, Eddy Saad, Karl Semaan, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
November 9, 2019
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum
Fred Saad, Christina Canil, Antonio Finelli, et al.
The Lancet. Oncology
|
March 1, 2023
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study
Toni K Choueiri, Masatoshi Eto, Robert Motzer, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 14, 2021
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers
Fred Saad, Sebastien J Hotte, Antonio Finelli, et al.
Nature Communications
|
February 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer
David C Müller, Andrew J Murtha, Jack V W Bacon, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 4, 2020
Determining generalizability of the Canadian Kidney Cancer information system (CKCis) to the entire Canadian kidney cancer population
Camilla Tajzler, Simon Tanguay, Ranjeeta Mallick, et al.
Clinical Genitourinary Cancer
|
May 7, 2019
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205
Sebastien J Hotte, Kim N Chi, Anthony M Joshua, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 8, 2018
Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials
Pierre I Karakiewicz, Emanuele Zaffuto, Anil Kapoor, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 15, 2023
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement
Aly-Khan A Lalani, Anil Kapoor, Naveen S Basappa, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
February 21, 2024
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum
Fred Saad, Sebastien J Hotte, Krista Noonan, et al.
JAMA Network Open
|
April 15, 2026
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
Martin Zarba, Eddy Saad, Karl Semaan, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
November 9, 2019
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum
Fred Saad, Christina Canil, Antonio Finelli, et al.
The Lancet. Oncology
|
March 1, 2023
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study
Toni K Choueiri, Masatoshi Eto, Robert Motzer, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 14, 2021
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers
Fred Saad, Sebastien J Hotte, Antonio Finelli, et al.
Nature Communications
|
February 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer
David C Müller, Andrew J Murtha, Jack V W Bacon, et al.
Page
of 6